The Benazepril study demonstrated that ACE inhibitors had a beneficial effect on the progression of CKD.20 The REIN study confirmed these results, by firstly demonstrating a reduction in the progression rate of CKD in patients with significant proteinuria (> 3 g/24 h) who were taking ramipril (an ACE inhibitor). Here, ACE is linked to chronic kidney disease.